Glioblastoma: open trials in Denmark

• NCT06914128

  A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

  Trial Treatment · Phase 1/2 · Bayer

  Rigshospitalet Copenhagen University Hospital | Oncology Department, Copenhagen · Odense University Hospital | Svendborg Sygehus - Oncology Department, Odense

  Registry updated 2026-10-28

• 2024-520105-39-00

  A dosimetry trial of uPAR targeted radioligand therapy in patients with glioblastoma

  Trial Treatment · Phase 1 · Curasight A/S

  Rigshospitalet, Copenhagen Oe

  Registry updated 2026-09-30

• NCT04094610

  A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.

  Rigshospitalet, Copenhagen Oe

  Registry updated 2026-09-25

• 2023-506998-35-00

  Phase III trial of lomustine/temozolomide (TMZ) combination therapy vs. standard TMZ therapy for newly diagnosed MGMT promoter methylated glioblastoma (IDHwt) patients +/- tumor treating fields (Optune)

  Trial Treatment · Phase 3 · Vaestra Goetalandsregionen

  Region Midtjylland, Aarhus N

  Registry updated 2026-08-27

• NCT05904119

  Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study

  Trial Treatment · Phase 3 · European Organisation for Research and Treatment of Cancer - EORTC

  Region Midtjylland, Aarhus N

  Registry updated 2026-06-08

• NCT07590726

  PIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors

  Trial Treatment · Copenhagen University Hospital, Rigshospitalet

  Rigshospitalet, Copenhagen

  Registry updated 2026-05-19

• NCT07284069

  Senicapoc and Perampanel for Newly Diagnosed Glioblastoma

  Trial Treatment · Early phase 1 · Aarhus University Hospital

  Region Midtjylland, Aarhus N · Aalborg University Hospital, Department of Neurosurgery, Gistrup · Rigshospitalet, Department of Neurosurgery, KBH Ø · Odense University Hospital, Odense

  Registry updated 2026-05-07

• NCT06419946

  Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

  Trial Treatment · Phase 3 · Vastra Gotaland Region

  Aarhus University Hospital, Aarhus

  Registry updated 2026-04-13

• 2024-515408-37-00

  MRI with hyperpolarized pyruvate in gliblastoma - a phase II study

  Trial Treatment · Phase 2 · Aarhus Universitet

  Aarhus Universitet, Aarhus N

  Registry updated 2025-11-28

• NCT06869577

  A Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma

  Trial Treatment · Copenhagen University Hospital, Rigshospitalet

  Copenhagen University Hospital, Rigshospitalet, Copenhagen

  Registry updated 2025-04-29

• 2024-519437-27-02

  A randomized phase III trial with lomustine versus lomustine and bevacizumab for patients with recurrent glioblastoma

  Trial Treatment · Phase 3 · Rigshospitalet

  Aalborg University Hospital, Aalborg · Aarhus University Hospital, Aarhus N · Copenhagen University Hospital, Copenhagen Oe · Odense University Hospital, Odense C

  Registry updated 2025-01-13

• NCT05768087

  Escalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma Patients

  Trial Treatment · University of Aarhus

  Danish Centre for Particle Therapy, Aarhus · Aarhus University Hospital, Dept. of Oncology, Aarhus

  Registry updated 2024-05-09

• NCT05908669

  Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma Multiforme

  Research · University of Aarhus

  Aarhus University, Aarhus

  Registry updated 2023-12-07

All Glioblastoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error